Giving 500 mg/kg of fructose‐1, 6‐bisphosphate intraperitoneally decreases hypoxic/ischaemic CNS injury of neonatal rats. Before administering fructose‐1, 6‐bisphosphate to human neonates, its toxicity must be determined in neonatal animals. Thus, saline or 4,000, 6,000, or 8,000 mg/kg of fructose‐1, 6‐bisphosphate was given intraperitoneally to normoxic 7 days old rats. One, 2, and 24 hr and 7 days later, blood Ca2+, P043–, blood urea nitrogen, and creatinine concentrations, and aspartate aminotransferase activity were measured. Organ pathology was determined at necropsy. Pups receiving 4,000 mg/kg of fructose‐1, 6‐bisphosphate survived without evidence of injury or toxicity. All animals receiving 8,000 mg/kg and 27 percent of those receiving 6,000 mg/kg of fructose‐1, 6‐bisphosphate died. Surviving fructose‐1, 6‐bisphosphate‐treated animals grew at the same rates and had similar weights as saline‐treated animals. Nineteen percent of pups given 6,000 or 8,000 mg/kg of fructose‐1, 6‐bisphosphate had mild perivascular fluid cuffing and/or microscopic pulmonary haemorrhage, but none of the animals given 4,000 mg/kg of the compound had evidence of injury. No other organ pathology was found in any of the animals. Renal and hepatic function were normal in all animals. Fructose‐1, 6‐bisphosphate administration was associated with a significant increase in the fructose‐1, 6‐bisphosphate concentration of blood. Administering 4,000 to 8,000 mg/kg of fructose‐1, 6‐bisphosphate significantly decreased Ca2+ concentrations and increased P043– concentrations 1 and 2 hrs after fructose‐1, 6‐bisphosphate administration. Similar changes in Ca2+ and P043– concentrations occurred after the administration of 10 mmol/kg of sodium phosphate. The wide margin of safety for fructose‐1, 6‐bisphosphate (8 times the dose needed to prevent or reduce CNS injury) may render fructose‐1, 6‐bisphosphate safe for use in neonates.